4013
COM:HMG
Dr. Sulaiman Al Habib Medical Group
- Stock
Last Close
271.20
21/11 12:16
Market Cap
97.93B
Beta: -
Volume Today
161.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|
average inventory | 337.89M - | 393.40M 16.43% | 448.64M 14.04% | 529.98M 18.13% | ||
average payables | 642.07M - | 716.65M 11.62% | 883.23M 23.24% | 1.12B 26.91% | ||
average receivables | 440.82M - | 815.17M 84.92% | ||||
book value per share | 12.55 - | 14.03 11.79% | 15.25 8.70% | 16.80 10.10% | 18.53 10.32% | |
capex per share | -2.09 - | -2.16 3.38% | -3.58 65.44% | -4.32 20.73% | -9.99 131.07% | |
capex to depreciation | -2.86 - | -2.38 16.75% | -3.98 67.03% | -4.89 22.90% | -11.18 128.51% | |
capex to operating cash flow | -0.69 - | -0.35 49.73% | -0.57 65.08% | -0.53 7.33% | -1.10 105.79% | |
capex to revenue | -0.15 - | -0.13 11.53% | -0.17 33.75% | -0.18 5.33% | -0.37 101.96% | |
cash per share | 3.42 - | 6.68 95.48% | 7.55 13.02% | 7.85 3.90% | 7.49 4.61% | |
days of inventory on hand | 30.92 - | 34.69 12.20% | 30.18 12.99% | 32.18 6.60% | 33.04 2.68% | |
days payables outstanding | 68.55 - | 57.36 16.32% | 59.73 4.13% | 63.08 5.61% | 74.28 17.76% | |
days sales outstanding | 38.72 - | 28.74 25.78% | ||||
debt to assets | 0.28 - | 0.28 0.46% | 0.28 1.68% | 0.28 0.80% | 0.31 11.93% | |
debt to equity | 0.53 - | 0.54 0.63% | 0.57 6.82% | 0.60 4.71% | 0.76 27.37% | |
dividend yield | 0.05 - | 0.01 70.68% | 0.02 21.56% | 0.01 11.77% | 0.01 2.19% | |
earnings yield | 0.05 - | 0.03 38.80% | 0.02 11.92% | 0.02 12.11% | 0.02 3.90% | |
enterprise value | 20.39B - | 38.44B 88.51% | 56.90B 48.02% | 77.84B 36.81% | 101.96B 30.98% | |
enterprise value over ebitda | 17.18 - | 25.73 49.78% | 30.69 19.29% | 38.51 25.49% | 42.10 9.30% | |
ev to operating cash flow | 19.25 - | 17.65 8.33% | 26.07 47.69% | 27.37 5.01% | 31.93 16.65% | |
ev to sales | 4.07 - | 6.56 61.33% | 7.85 19.67% | 9.37 19.35% | 10.72 14.48% | |
free cash flow per share | 0.93 - | 4.06 335.41% | 2.66 34.57% | 3.80 43.16% | -0.87 122.85% | |
free cash flow yield | 0.02 - | 0.04 119.70% | 0.02 55.81% | 0.02 4.93% | -0.00 117.71% | |
graham net net | -7.23 - | -5.32 26.40% | -7.01 31.64% | -8.07 15.17% | -15.74 95.06% | |
graham number | 26.50 - | 30.86 16.44% | 36.74 19.07% | 42.22 14.90% | 49.37 16.93% | |
income quality | 1.17 - | 1.93 64.71% | 1.45 24.72% | 1.58 8.86% | 1.56 1.40% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | 31.03 - | 22.99 25.92% | 38.69 68.29% | -84.28 317.84% | 25.14 129.83% | |
interest debt per share | 6.76 - | 7.65 13.21% | 8.84 15.43% | 10.00 13.23% | 14.38 43.72% | |
inventory turnover | 11.81 - | 10.52 10.87% | 12.09 14.93% | 11.34 6.20% | 11.05 2.61% | |
invested capital | 0.53 - | 0.54 0.63% | 0.57 6.82% | 0.60 4.71% | 0.76 27.37% | |
market cap | 19.25B - | 38.15B 98.18% | 56.49B 48.07% | 77.07B 36.43% | 99.40B 28.97% | |
net current asset value | -591.52M - | -543.00M 8.20% | -1.17B 114.89% | -2.32B 98.65% | -4.84B 108.78% | |
net debt to ebitda | 0.96 - | 0.19 79.73% | 0.22 13.61% | 0.38 73.02% | 1.06 176.17% | |
net income per share | 2.49 - | 3.02 21.29% | 3.93 30.43% | 4.72 19.91% | 5.85 23.94% | |
operating cash flow per share | 3.03 - | 6.22 105.65% | 6.24 0.22% | 8.12 30.28% | 9.12 12.28% | |
payables turnover | 5.32 - | 6.36 19.51% | 6.11 3.96% | 5.79 5.31% | 4.91 15.08% | |
receivables turnover | 9.43 - | 12.70 34.73% | ||||
research and ddevelopement to revenue | ||||||
return on tangible assets | 0.10 - | 0.11 8.32% | 0.13 14.21% | 0.13 3.17% | 0.13 1.27% | |
revenue per share | 14.33 - | 16.75 16.85% | 20.72 23.69% | 23.74 14.62% | 27.17 14.41% | |
roe | 0.20 - | 0.21 8.50% | 0.26 19.98% | 0.28 8.91% | 0.32 12.35% | |
roic | 0.11 - | 0.13 14.74% | 0.16 19.11% | 0.16 5.42% | 0.18 6.43% | |
sales general and administrative to revenue | 0.02 - | 0.02 18.05% | 0.01 27.62% | 0.02 13.21% | 0.02 2.47% | |
shareholders equity per share | 12.55 - | 14.03 11.79% | 15.25 8.70% | 16.80 10.10% | 18.53 10.32% | |
stock based compensation to revenue | ||||||
tangible asset value | 4.59B - | 5.09B 10.84% | 5.53B 8.62% | 6.11B 10.47% | 6.82B 11.71% | |
tangible book value per share | 13.12 - | 14.54 10.84% | 15.79 8.62% | 17.44 10.47% | 19.49 11.71% | |
working capital | 1.79B - | 2.16B 20.46% | 2.09B 3.26% | 1.57B 24.72% | 838.68M 46.59% |
All numbers in (except ratios and percentages)